WILMINGTON, Mass., Feb. 5 /PRNewswire-FirstCall/ -- CardioTech International, Inc. , a developer and manufacturer of advanced materials and medical devices for the treatment of cardiovascular and other diseases, announced today that it will release its fiscal 2008 third quarter financial results before the market opens on Tuesday, February 12, 2008. Following the release, the Company will host a conference call for investors at 2:30 p.m. ET (11:30 a.m. PT) to discuss its fiscal third quarter results and recent developments.
Participants should dial-in (866) 802-4355 Conference ID# 1191648 or (703) 639-1323 outside the U.S. Please dial-in 10 minutes before the call is scheduled to begin. A replay of the call will be available for two weeks following the call at (888)-266-2081 ID# 1191648 and on the Company’s website.
About CardioTech International:
CardioTech is a developer of advanced polymer materials and manufacturer of medical products for the treatment and diagnosis of a broad range of disease states. The Company’s business model leverages its proprietary materials science technology and manufacturing expertise in order to expand its product sales and royalty and license fee income. It develops next generation polymers and manufactures new and complex medical devices to customers’ unique specifications. CardioTech is conducting its first clinical trial for regulatory approval in Europe for its CardioPass synthetic coronary bypass graft. More information about CardioTech is available at its website: http://www.cardiotech-inc.com.
general-info@cardiotech-inc.cominfo@vmwcom.com
CONTACT: Eric Walters, Vice President & Chief Financial Officer,
CardioTech International, Inc., +1-978-657-0075,
general-info@cardiotech-inc.com; Sylvia Dresner, Senior Vice President VMW
Corporate & Investor Relations, +1-212-616-6161, info@vmwcom.com
Web site: http://www.cardiotech-inc.com//
